跳至主要内容
临床试验/IRCT20190208042654N1
IRCT20190208042654N1已完成3 期

The Comparison of Levetiracetam and Piracetam efficacy on severe Breath Holding Spells; A Randomized Controlled clinical trial

Esfahan University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 months 至 6 years(—)
性别
All

入选标准

  • Patients with severe breath holding attacks at least 3 times a month
  • Aged less than 6 years and more than 6 months
  • Normal growth and development
  • Normal cardiovascular, cerebral and neurological examinations
  • Not having electrolyte disturbances, hypoglycemia and iron deficiency
  • Not having any seizure or neurological problem or epilepsy

排除标准

  • Inability to follow up
  • occurrence of any drug reaction or any other problem during treatment
  • occurrence of seizure or any neurological disorders during the study

研究者

相似试验